Myongji Hospital
14
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
7.1%
1 terminated/withdrawn out of 14 trials
85.7%
-0.8% vs industry average
43%
6 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
Role: collaborator
Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery
Role: collaborator
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Role: collaborator
CABG Based on CT-FFR Versus Conventional Coronary Angiography
Role: lead
Adaptive Nutrition Therapy in Hemodialysis
Role: collaborator
Transumbilical Laparoscopy-assisted Appendectomy
Role: lead
Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
Role: collaborator
Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
Role: collaborator
Study of the Durability of Glycemic Control With Nateglinide
Role: collaborator
The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder
Role: collaborator
The Efficacy of Intensive Nutritional Supplement in Patient With Stroke
Role: collaborator
Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction
Role: collaborator
The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency Department
Role: collaborator
Suicidal Ideation and Behavior in Korean Adolescents With Depression
Role: collaborator
All 14 trials loaded